0001171843-18-004989.txt : 20180703
0001171843-18-004989.hdr.sgml : 20180703
20180703081958
ACCESSION NUMBER: 0001171843-18-004989
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180629
FILED AS OF DATE: 20180703
DATE AS OF CHANGE: 20180703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Eldridge, George Arthur
CENTRAL INDEX KEY: 0001622905
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36694
FILM NUMBER: 18934738
BUSINESS ADDRESS:
STREET 1: 64 DAMIEN ROAD
CITY: WELLESLEY
STATE: MA
ZIP: 02481
BUSINESS PHONE: 617-290-9883
MAIL ADDRESS:
STREET 1: 64 DAMIEN ROAD
CITY: WELLESLEY
STATE: MA
ZIP: 02481
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC
CENTRAL INDEX KEY: 0001359931
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-0102
MAIL ADDRESS:
STREET 1: 200 WEST STREET
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
ownership.xml
X0306
4
2018-06-29
0
0001359931
PROTEON THERAPEUTICS INC
PRTO
0001622905
Eldridge, George Arthur
C/O PROTEON THERAPEUTICS
200 WEST STREET
WALTHAM
MA
02451
0
1
0
0
Sr VP, CFO, Treasr, Asst Secy
Common Stock
2018-06-29
5
A
0
E
10000
1.615
A
26684
D
Common Stock
1545
I
See footnote
The shares were acquired under the Issuer's 2014 Employee Stock Purchase Plan for the plan period of January 1, 2018 through June 30, 2018 in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
These securities were purchased by the reporting person as custodian for three minor children under the Uniform Transfers to Minors Act. The reporting person disclaims beneficial ownership of these shares, and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or for any other purpose.
/s/ George A. Eldridge
2018-07-03